| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6824275 | Schizophrenia Research | 2015 | 8 Pages |
Abstract
The PSAS can be useful to describe the whole hallucination and its evolution during the course of the disease and treatment in schizophrenia and PD. Moreover, it can allow us to undertake a clinic-pathological comparison of hallucination modalities between these two diseases, to enhance our understanding of their precise neurological mechanisms.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
I. de Chazeron, B. Pereira, I. Chereau-Boudet, G. Brousse, D. Misdrahi, G. Fénelon, A.-M. Tronche, R. Schwan, C. Lançon, A. Marques, B. Debilly, F. Durif, P.M. Llorca,